M1 Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
M1 Capital Management's ABBV Position: Q3 2026 in Review
M1 Capital Management reduced its AbbVie (ABBV) stake by 0.11% in Q3 2026, selling an estimated $513 and leaving 1,767 shares worth $462K. The position accounts for 0.17% of the portfolio, ranked #72.
M1 Capital Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- M1 Capital Management held 1,767 shares of AbbVie worth $462K as of Q3 2026.
- M1 Capital Management sold 2 AbbVie shares in Q3 2026, an estimated $513.
- AbbVie made up 0.17% of M1 Capital Management's portfolio in Q3 2026, its #72 holding.
- M1 Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on M1 Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.